Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

A groundbreaking vaccine for norovirus, the notorious winter vomiting bug, is set to enter final-stage trials in the UK ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the “burden on ...

Social media users are spreading new levels of misinformation based on discredited claims that nanobots are lurking in ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...

Looking at options history for Moderna MRNA we detected 21 trades. If we consider the specifics of each trade, it is accurate ...